GLP1-S

CAS: 910463-68-2

|

SKU:GLP-1-S

GLP1-S is a synthetic GLP-1 receptor agonist analogue engineered for laboratory research involving incretin-related receptor signaling and peptide pharmacokinetic modification strategies.

Current Lot ID
2602-C101-10-001, 2602-C101-30-001
Third-party analytical validation via HPLC & MS / Sequence matching verified

Research Use Only

This product is intended for research purposes only.

Configure Order

Select quantity and verify pricing.
SELECT CONCENTRATION
VOLUME PRICING
1
Technical Specification

Scientific Context & Applications

Research Profile Access

View extended technical data, molecular targets, signaling pathways, and historical research timelines for GLP1-S

Scientific Context
Molecular classification and background.

GLP1-S is classified as a long-acting GLP-1 receptor research peptide incorporating structural modifications designed to extend molecular stability in experimental systems. These modifications include a spacer region and a lipid-based side chain that facilitates reversible albumin association, reducing enzymatic degradation in vitro. In research settings, GLP1-S is used to examine:
  • GLP-1 receptor binding dynamics
  • Prolonged receptor engagement and signaling duration
  • Structural strategies for peptide stabilization
All studies focus on molecular and cellular signaling behavior, without clinical or therapeutic interpretation.

Laboratory Applications
Experimental models and settings.

GLP1-S is utilized in non-clinical research environments as a reference peptide and signaling probe for incretin-related pathway investigation. Reported experimental contexts include:
  • GLP-1 Receptor Signaling Studies Used in cellular systems to evaluate receptor activation patterns, downstream second-messenger signaling, and transcriptional response markers.
  • Comparative Peptide Stability Research Applied in laboratory assays examining structural modifications and peptide persistence under controlled conditions.
  • Neuronal & Cardiovascular Cell Research Models Examined in cell-based systems to explore GLP-1 receptor–associated intracellular signaling pathways, without disease or outcome framing.
  • Hepatic & Metabolic Signaling Models Utilized to investigate receptor-mediated signaling responses in liver-derived or metabolic cell models at the molecular level.
All applications remain strictly investigational and confined to laboratory research use only. Research Scope & Limitations Research involving GLP1-S is exploratory and model-dependent. Observations reported in cellular or animal research systems do not predict outcomes in humans or animals outside controlled laboratory environments. No conclusions regarding safety, efficacy, disease relevance, or clinical application have been established.

Scientific References
Peer-reviewed literature data.

Selected peer-reviewed literature examining GLP-1 analogue design and receptor signaling mechanisms:
  1. Lau J, et al. Design and characterization of GLP-1 analogues. Journal of Medicinal Chemistry
  2. Knudsen LB, et al. Structural modification strategies for GLP-1 peptides. Nature Reviews Drug Discovery
(Clinical outcomes, disease-specific trials, and therapeutic studies are intentionally excluded from commerce pages.)

Related Research Compounds

Explore compounds frequently investigated in similar research domains and signaling pathways.

Hospira Bac Water – 30ml

Kisspeptin

374675-21-5

GLP1-S

910463-68-2

5-Amino-1MQ

42464-96-0

Immune & Inflammatory Signaling Bundle

GH Axis & Endocrine Signaling Bundle

Neuro-Signaling & Neuropeptide Bundle

Mitochondrial & Cellular Energy Bundle

Structural & Cytoskeletal Research Bundle